![business-21856_1280](https://pharmaphorum.com/wp-content/uploads/2020/11/business-21856_1280.jpg)
NICE okays Roche liver cancer immunotherapy, Sanofi’s rare d...
Previously-untreated patients with hepatocellular carcinoma (HCC), a common form of liver cancer, will have an immunotherapy-based treatment option after NICE gave the nod to NHS funding of